Average Insider

Where insiders trade, we follow

$CMND
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Healthcare
Sector
Biotechnology
Industry
Adi Zuloff-Shani
CEO
4
Employees
$3.07
Current Price
$321.15K
Market Cap
52W Low$2.10
Current$3.070.2% above low, 99.8% below high
52W High$524.00

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells13$90,821.8127,424
1 monthBuys11$330,334.962,159,0522.79:1
Sells14$118,520.31252,615
2 monthsBuys11$330,334.962,159,0522.79:1
Sells14$118,520.31252,615
3 monthsBuys11$330,334.962,159,0522.79:1
Sells14$118,520.31252,615
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jun 16, 2026
HRT FINANCIAL LP
10% Owner
Sale22,139$3.31$73,191.53View Details
Jun 15, 2026
HRT FINANCIAL LP
10% Owner
Sale3,183$3.32$10,567.56View Details
Jun 12, 2026
HRT FINANCIAL LP
10% Owner
Sale2,102$3.36$7,062.72View Details
Jun 10, 2026
HRT FINANCIAL LP
10% Owner
Purchase2,159,052$0.15$330,334.96View Details
Jun 11, 2026
HRT FINANCIAL LP
10% Owner
Sale225,191$0.12$27,698.49View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.5.2